We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14B
AUM Growth
-$1.09B
Cap. Flow
+$34.5M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.95%
Holding
1,364
New
25
Increased
674
Reduced
255
Closed
34

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$233M
2
WPC icon
W.P. Carey
WPC
+$93M
3
EXR icon
Extra Space Storage
EXR
+$81.4M
4
IRM icon
Iron Mountain
IRM
+$41.1M
5
EGP icon
EastGroup Properties
EGP
+$39.7M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$154M
2
KRMA
Global X Conscious Companies ETF
KRMA
+$114M
3
CUZ icon
Cousins Properties
CUZ
+$106M
4
FR icon
First Industrial Realty Trust
FR
+$66.7M
5
PSA icon
Public Storage
PSA
+$53.2M

Sector Composition

Rank Sector Weight
1 Real Estate 53.25%
2 Technology 12.67%
3 Healthcare 4.74%
4 Consumer Discretionary 4.53%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
1101
Cytokinetics
CYTK
$10.8B
$11K ﹤0.01%
381
– –
DNLI icon
1102
Denali Therapeutics
DNLI
$3.83B
$11K ﹤0.01%
546
– –
KRYS icon
1103
Krystal Biotech
KRYS
$10.8B
$11K ﹤0.01%
96
– –
AKRO
1104
DELISTED
Akero Therapeutics
AKRO
$10K ﹤0.01%
188
– –
MDGL icon
1105
Madrigal Pharmaceuticals
MDGL
$12.5B
$10K ﹤0.01%
69
– –
OUT icon
1106
Outfront Media
OUT
$5.77B
$10K ﹤0.01%
985
+165
+20% +$2.06K
RARE icon
1107
Ultragenyx Pharmaceutical
RARE
$2.57B
$10K ﹤0.01%
282
– –
RVMD icon
1108
Revolution Medicines
RVMD
$39.1B
$10K ﹤0.01%
357
– –
MRTX
1109
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$10K ﹤0.01%
232
– –
AMPH icon
1110
Amphastar Pharmaceuticals
AMPH
$903M
$9K ﹤0.01%
194
– –
NUVL
1111
DELISTED
Nuvalent
NUVL
$9K ﹤0.01%
205
– –
PRTA icon
1112
Prothena Corp
PRTA
$452M
$9K ﹤0.01%
195
– –
VFSWW
1113
VinFast Auto Ltd Warrant
VFSWW
$9K ﹤0.01%
+2,500
New +$10.1K
XENE icon
1114
Xenon Pharmaceuticals
XENE
$6.3B
$9K ﹤0.01%
252
– –
HRMY icon
1115
Harmony Biosciences
HRMY
$2.08B
$8K ﹤0.01%
239
– –
PACB icon
1116
Pacific Biosciences
PACB
$447M
$8K ﹤0.01%
909
– –
VTYX
1117
DELISTED
Ventyx Biosciences
VTYX
$8K ﹤0.01%
228
– –
BEAM icon
1118
Beam Therapeutics
BEAM
$2.71B
$7K ﹤0.01%
283
– –
NVCR icon
1119
NovoCure
NVCR
$1.87B
$7K ﹤0.01%
422
-9,766
-96% -$282K
ACLX
1120
DELISTED
Arcellx
ACLX
$6K ﹤0.01%
176
– –
CRNX icon
1121
Crinetics Pharmaceuticals
CRNX
$8.88B
$6K ﹤0.01%
199
– –
GMAB icon
1122
Genmab
GMAB
$17.7B
$6K ﹤0.01%
172
– –
IRWD icon
1123
Ironwood Pharmaceuticals
IRWD
$626M
$6K ﹤0.01%
573
– –
PTCT icon
1124
PTC Therapeutics
PTCT
$6.3B
$6K ﹤0.01%
289
– –
RCKT icon
1125
Rocket Pharmaceuticals
RCKT
$344M
$6K ﹤0.01%
304
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2023 Portfolio in Review

As of Q3 2023, Daiwa Securities Group held 1,364 positions worth $14B, down 7.2% from $15.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.3%. Daiwa Securities Group opened 25 new positions and exited 34, leaving the 1,364-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 53% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2023 buy was Kenvue: 139,472 shares worth $2.8M.
  • Daiwa Securities Group added most to American Tower in Q3 2023, an estimated $233M increase.
  • Daiwa Securities Group's biggest Q3 2023 reduction was Digital Realty Trust, cutting an estimated $154M.
  • Daiwa Securities Group fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $5.38M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $14B portfolio in Q3 2023.
  • Daiwa Securities Group opened 25 new positions and closed 34 in Q3 2023.
  • Daiwa Securities Group's portfolio value fell 7.2% quarter-over-quarter to $14B.

Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.